Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liangxue Shugan Fang is a traditional Chinese medicine (TCM) herbal formula used primarily in the management of various conditions, including as an adjunct therapy for postoperative estrogen receptor-positive breast cancer patients. The formula is composed of multiple herbs traditionally believed to "cool the blood" and "soothe the liver," concepts rooted in TCM theory. Its mechanism of action is not fully elucidated by modern pharmacology, but it is thought to exert anti-inflammatory and immunomodulatory effects through multi-target interactions typical of complex herbal formulas. Clinical studies have investigated its use for improving quality of life and reducing recurrence risk in breast cancer patients after surgery[2]. The specific composition may vary by manufacturer or clinical protocol.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on liangxue shugan fang.